+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dermatophytosis Treatment Market by Treatment, Product, Sales Channel - Global Forecast 2025-2030- Product Image
Dermatophytosis Treatment Market by Treatment, Product, Sales Channel - Global Forecast 2025-2030- Product Image
Sale

Dermatophytosis Treatment Market by Treatment, Product, Sales Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967744
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dermatophytosis Treatment Market grew from USD 12.63 billion in 2023 to USD 13.33 billion in 2024. It is expected to continue growing at a CAGR of 5.88%, reaching USD 18.85 billion by 2030.

Dermatophytosis treatment encompasses interventions aimed at managing and eradicating fungal infections caused by dermatophytes on skin, hair, and nails. The scope of this market aligns with the rising prevalence of dermatophytic infections globally, driven by factors like increased urbanization, growing pet ownership, and higher prevalence of immunocompromised conditions. Necessarily applied in dermatology, veterinary clinics, and hospitals, these treatments include antifungal creams, oral medications, and new oral and topical therapies. The end-use scope primarily covers healthcare providers, including dermatologists and general practitioners, as well as direct consumer applications through over-the-counter products.

Key growth influencers in the dermatophytosis treatment market include the rising awareness about fungal infections and their management, along with advancements in drug delivery systems and increased availability of over-the-counter products. The latest opportunities lie in leveraging technologies such as nanotechnology for improved drug efficacy and developing cost-effective therapies catering to emerging markets. Additionally, the expansion of telehealth services presents an opportunity to enhance patient education and treatment adherence. However, growth is challenged by limitations such as the side effects associated with oral antifungals, the emergence of antifungal resistance, and the often long and recurrent nature of dermatophytic infections, necessitating persistent treatment.

Innovation and research should focus on improving existing treatment formulations to reduce side effects and resistance patterns while enhancing efficacy through novel drug delivery systems like liposomal formulations. Furthermore, expanding research on natural antifungal compounds and alternative medicine could provide new market avenues. Business growth would also benefit from increased collaboration with healthcare providers to strengthen distribution channels and enhance patient education programs. The dermatophytosis treatment market is characterized by moderate competition, with leading pharma companies focusing on R&D to introduce innovative solutions while penetrating deeper into untapped markets for expansive growth.

Understanding Market Dynamics in the Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Significant prevalence of tinea pedis among the population
    • Growing awareness about dermatophytosis disorders
  • Market Restraints
    • Considerable issues associated with product recall
  • Market Opportunities
    • Research focused on new antifungal agents and new formulations
    • Growing availability of OTC dermatological products through online sales channels
  • Market Challenges
    • Capital-intensive and time-consuming product approval process

Exploring Porter’s Five Forces for the Dermatophytosis Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Dermatophytosis Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Dermatophytosis Treatment Market

External macro-environmental factors deeply influence the performance of the Dermatophytosis Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Dermatophytosis Treatment Market

The Dermatophytosis Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatophytosis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc, Alva-Amco Pharmacal Companies, Inc, Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Blueberry Therapeutics Ltd., Cipla Ltd., Creative Biolabs, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Ipca Laboratories Ltd, Leeford Healthcare Ltd, Mylan N.V., Novartis AG, Oaknet Healthcare Pvt Ltd, Perrigo Company PLC, ProFoot, Inc., Quinnova Pharmaceuticals Inc., Sebela Pharmaceuticals Holdings Inc., Steris Healthcare PVT Ltd, Sun Pharmaceutical Industries Ltd., Taisho Pharmaceutical Co., Ltd., and Vibcare Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Dermatophytosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment
    • Combination Therapies
    • Oral Antifungals
    • Topical Antifungals
      • Cream & Lotion
      • Gel
      • Powder
      • Spray
  • Product
    • Over-the-Counter (OTC) Drugs
    • Prescription Drugs
  • Sales Channel
    • Offline
      • Hospitals & Clinics
      • Retail Pharmacies
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant prevalence of tinea pedis among the population
5.1.1.2. Growing awareness about dermatophytosis disorders
5.1.2. Restraints
5.1.2.1. Considerable issues associated with product recall
5.1.3. Opportunities
5.1.3.1. Research focused on new antifungal agents and new formulations
5.1.3.2. Growing availability of OTC dermatological products through online sales channels
5.1.4. Challenges
5.1.4.1. Capital-intensive and time-consuming product approval process
5.2. Market Segmentation Analysis
5.2.1. Treatment:
5.2.2. Sales Channel:
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Dermatophytosis Treatment Market, by Treatment
6.1. Introduction
6.2. Combination Therapies
6.3. Oral Antifungals
6.4. Topical Antifungals
6.4.1. Cream & Lotion
6.4.2. Gel
6.4.3. Powder
6.4.4. Spray
7. Dermatophytosis Treatment Market, by Product
7.1. Introduction
7.2. Over-the-Counter (OTC) Drugs
7.3. Prescription Drugs
8. Dermatophytosis Treatment Market, by Sales Channel
8.1. Introduction
8.2. Offline
8.2.1. Hospitals & Clinics
8.2.2. Retail Pharmacies
8.3. Online
9. Americas Dermatophytosis Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Dermatophytosis Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Dermatophytosis Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Bayer Elevates Fungal Infection Treatment in India with Enhanced Canesten Range
12.3.2. Glenmark Pharmaceuticals Launches 'Hello Skin' Chatbot in Collaboration with IADVL to Combat Dermatophytosis in India
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DERMATOPHYTOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DERMATOPHYTOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DERMATOPHYTOSIS TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COMBINATION THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ORAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY CREAM & LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 41. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 43. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. CANADA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 68. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 70. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. CHINA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 73. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 75. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. INDIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. JAPAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. THAILAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. DENMARK DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. EGYPT DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. FINLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. FRANCE DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. GERMANY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 159. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 161. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. ITALY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. NORWAY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 179. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 181. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. POLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 184. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 186. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. QATAR DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SPAIN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. TURKEY DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY TOPICAL ANTIFUNGALS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM DERMATOPHYTOSIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 234. DERMATOPHYTOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. DERMATOPHYTOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Dermatophytosis Treatment Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Aetna Inc
  • Alva-Amco Pharmacal Companies, Inc
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd.
  • Cipla Ltd.
  • Creative Biolabs
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Ipca Laboratories Ltd
  • Leeford Healthcare Ltd
  • Mylan N.V.
  • Novartis AG
  • Oaknet Healthcare Pvt Ltd
  • Perrigo Company PLC
  • ProFoot, Inc.
  • Quinnova Pharmaceuticals Inc.
  • Sebela Pharmaceuticals Holdings Inc.
  • Steris Healthcare PVT Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Vibcare Pharma Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 13.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 18.85 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Dermatophytosis Treatment Global Market Report 2024 - Product Image

Dermatophytosis Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Natural Products for Treatment of Skin and Soft Tissue Disorders - Product Image

Natural Products for Treatment of Skin and Soft Tissue Disorders

  • Book
Ringworm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Ringworm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 133 Pages
  • Global
From
Tinea Pedis Treatment Market by Type, Indication Type, Route Of Administration, Sales Channel - Global Forecast 2025-2030 - Product Image

Tinea Pedis Treatment Market by Type, Indication Type, Route Of Administration, Sales Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Dermatology Market by Product Type, Application, End User, Treatment, Patient Age Group - Global Forecast 2025-2030 - Product Image

Dermatology Market by Product Type, Application, End User, Treatment, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From

About the Dermatophytosis Drug Market

Dermatophytosis is a fungal infection of the skin, hair, and nails caused by dermatophytes. Dermatophytosis drugs are used to treat this condition. These drugs are typically antifungal medications, such as terbinafine, itraconazole, and fluconazole. They are available in both topical and oral forms. In addition, some dermatophytosis drugs are used to treat other fungal infections, such as candidiasis and tinea versicolor. The dermatophytosis drug market is a subset of the larger dermatological drug market. It is composed of a variety of products, including antifungal medications, topical creams, and ointments. These products are used to treat a range of fungal infections, including dermatophytosis. Some companies in the dermatophytosis drug market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.